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pDITORIAL COMMENT
iet and Exercise for
erimenopausal Women
ifestyle Interventions Can
ecrease Cardiovascular Risk*
anette K. Wenger, MD, FACC
tlanta, Georgia
arlier this year, the American Heart Association and multiple
artner professional organizations published evidence-based
uidelines for the prevention of cardiovascular disease in
omen (1). These guidelines highlight the top priority of
ncorporating into clinical practice the advocacy of lifestyle
odifications both for preventing the development of coronary
isk factors and for decreasing the risk of coronary heart
isease. Such interventions include smoking cessation, regular
hysical activity, a heart-healthy diet, and weight maintenance/
eduction. Although coronary heart disease is the predominant
ause of mortality for adult women in the U.S., screening for
oronary risk factors and coronary risk reduction interventions
emains underused in women. A recent survey (2) identified
hat most U.S. women are unaware of their cholesterol levels
nd that few personally perceive themselves as at risk for
ardiovascular events.
See page 579
In this issue of the Journal, a randomized controlled trial
f a dietary and exercise intervention depicts its efficacy for
erimenopausal women in slowing the progression of ath-
rosclerosis, as ascertained by a noninvasive measurement of
arotid intima-media thickness (3). These data from the
omen’s Healthy Lifestyle Project suggest that perimeno-
ause offers the unique opportunity for coronary risk reduc-
ion in women. The recent persuasive evidence from ran-
omized controlled clinical trials (4–6), that the use of
enopausal hormone therapy by both healthy women and
omen with established heart disease failed to prevent
ardiovascular events and rather entailed cardiovascular and
ther risks, has refocused attention on interventions of
ocumented efficacy in preventing cardiovascular disease in
omen. Of note is that menopausal hormone use initiated
y small numbers of women in the Women’s Healthy
ifestyle Project between the baseline visit and study end
id not alter the effect of the diet and exercise intervention.
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Division of Cardiology, Emory University School of Medicine, Gradytemorial Hospital, and Emory Heart and Vascular Center, Atlanta, Georgia.s appropriately cited by the authors, research is requisite to
elineate whether a comparable diet and exercise interven-
ion initiated later after menopause would provide similar
enefit.
In the U.S., physical inactivity is more prevalent among
omen than men and is more likely to be present among
lder than younger women, among the less affluent, and
mong women of racial or ethnic minorities. Contemporary
eports confirm that one third of Caucasian women are
hysically inactive, in contrast to more than one half of
lack and Hispanic women. More than half of Caucasian
omen are overweight or obese, compared with about three
ourths of black and Mexican-American women (7).
Weight reduction is associated with an improvement in
nsulin resistance, in inflammatory markers such as
-reactive protein, in systolic and diastolic blood pressures,
nd in the lipid profile (8). Regular exercise such as 30 min
f jogging, swimming, or brisk walking daily can lower
evels of total cholesterol, low-density lipoprotein, and
riglycerides and raise high-density lipoprotein concentra-
ions. Exercise has been documented to decrease the risk of
oronary heart disease by 40%, stroke by 30%, and the
evelopment of type II diabetes by 30% (9).
An earlier report from the Women’s Healthy Lifestyle
roject (10) clinical trial established that the modest and
ttainable dietary and physical activity intervention pre-
ented weight gain and was associated with significant
eductions in total cholesterol and triglyceride levels, waist
ircumference, systolic and diastolic blood pressures, and
lucose levels. The intervention was designed to reduce
ietary fat intake to 25% of daily calories, lower saturated fat
ntake to 7% of calories, and decrease dietary cholesterol to
00 mg daily. A reduction in caloric intake to 1,300 kcal
aily and an increase in leisure time physical activity of
,000 to 1,500 kcal energy expenditure weekly were used to
acilitate weight loss/control. The study design involved
ntensive group programs for the initial 6 months and
ndividual and group sessions during months 6 through 54.
he current documentation of a favorable effect on a
ubclinical measure of atherosclerosis, carotid intima-media
hickness, is concordant with the hypothesis that risk
eduction favorably impacts the pathophysiologic alterations
f atherosclerosis.
Unanswered, pivotal questions remain as to whether the
hysiologic changes of menopause per se trigger an increase
n traditional coronary risk factors, whether menopause
nd/or its hormonal milieu increase concentrations of novel
r as yet-unidentified risk factors that increase coronary risk,
hether lifestyle attributes of menopausal women (includ-
ng weight gain and physical inactivity) increase coronary
isk, whether any of these represent a continuum of risk
ssociated with aging without an abrupt increase at meno-
ause, and/or whether these variables differ in subpopula-
ions of women.
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